Page last updated: 2024-08-16

salmeterol xinafoate and Constriction, Pathological

salmeterol xinafoate has been researched along with Constriction, Pathological in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukkuda, T	1
Aoshima, Y; Chida, K; Enomoto, N; Fujisawa, T; Hashizume, H; Inui, N; Nakamura, Y; Sato, J; Suda, T; Yokomura, K	1
Langdon, RB; Legrand, C; Loeys, T; Pearlman, DS; Philip, G; Reiss, TF; Villarán, C	1
Chuchalin, AG; Gunawardena, KA; Helbling, A; Jasan, J; Langley, SJ; Laurenzi, M; Lee, TH; Leff, JA; Menten, J; O'Neill, SJ; Suskovic, S; van Noord, JA; Villaran, C	1

Reviews

1 review(s) available for salmeterol xinafoate and Constriction, Pathological

Article	Year
[Recent study on pathogenesis of bronchial asthma and the therapeutic strategy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Mar-10, Volume: 93, Issue:3 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchi; Bronchial Diseases; Bronchial Hyperreactivity; Bronchitis; Constriction, Pathologic; Drug Therapy, Combination; Eosinophilia; Glucocorticoids; Humans; Salmeterol Xinafoate; Theophylline	2004

Article

Year

[Recent study on pathogenesis of bronchial asthma and the therapeutic strategy].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Mar-10, Volume: 93, Issue:3

Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchi; Bronchial Diseases; Bronchial Hyperreactivity; Bronchitis; Constriction, Pathologic; Drug Therapy, Combination; Eosinophilia; Glucocorticoids; Humans; Salmeterol Xinafoate; Theophylline

2004

Trials

2 trial(s) available for salmeterol xinafoate and Constriction, Pathological

Article	Year
Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. Chest, 2007, Volume: 132, Issue:3 Topics: Acetates; Adolescent; Adult; Albuterol; Anti-Asthmatic Agents; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Exercise; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Salmeterol Xinafoate; Sulfides	2007
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. The Journal of allergy and clinical immunology, 1999, Volume: 104, Issue:3 Pt 1 Topics: Acetates; Adolescent; Adult; Albuterol; Asthma, Exercise-Induced; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Single-Blind Method; Sulfides	1999

Article

Year

Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction.

Chest, 2007, Volume: 132, Issue:3

Topics: Acetates; Adolescent; Adult; Albuterol; Anti-Asthmatic Agents; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Exercise; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Salmeterol Xinafoate; Sulfides

2007

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group.

The Journal of allergy and clinical immunology, 1999, Volume: 104, Issue:3 Pt 1

Topics: Acetates; Adolescent; Adult; Albuterol; Asthma, Exercise-Induced; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Single-Blind Method; Sulfides

1999

Other Studies

1 other study(ies) available for salmeterol xinafoate and Constriction, Pathological

Article	Year
Management of interleukin-2-induced severe bronchoconstriction. The European respiratory journal, 2007, Volume: 29, Issue:3 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Inflammatory Agents; Antineoplastic Agents; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Delayed-Action Preparations; Drug Administration Schedule; Female; Fluticasone; Forced Expiratory Volume; Hemangioendothelioma; Humans; Infusions, Intravenous; Injections, Intralesional; Interleukin-2; Male; Middle Aged; Premedication; Salmeterol Xinafoate; Skin Neoplasms	2007

Article

Year

Management of interleukin-2-induced severe bronchoconstriction.

The European respiratory journal, 2007, Volume: 29, Issue:3

Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Inflammatory Agents; Antineoplastic Agents; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Delayed-Action Preparations; Drug Administration Schedule; Female; Fluticasone; Forced Expiratory Volume; Hemangioendothelioma; Humans; Infusions, Intravenous; Injections, Intralesional; Interleukin-2; Male; Middle Aged; Premedication; Salmeterol Xinafoate; Skin Neoplasms

2007